ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OM vs VANI // OPERATING MARGIN

Outset Medical Inc. (NASDAQ) VS. Vivani Medical Inc. (NASDAQ) • 15-METRIC TALLY: OM 3 — VANI 1
■ METRIC PARITY
operating-margins
-55.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OM VS. VANI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OM VANI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 39.10% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -28.00% -35.00% +7.00 OM /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -24.79% — TIE /fcf-yield <GO>
Operating Margin ACTIVE -55.80% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 5.10% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 3/9 +3.00 OM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 55.8 45.0 +10.80 OM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 3.6x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $78.8M $102.8M -$24.1M VANI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OM REV VANI REV OM GROSS % VANI GROSS % OM FCF VANI FCF
FY 2025 $119.5M $0 39.1% — -$47.1M -$25.5M
FY 2024 $113.7M $0 33.9% — -$117.2M -$21.3M
FY 2023 $130.4M $0 — — -$131.4M -$23.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OM // BETA —
VANI // BETA —